A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic BRAF-Mutant Colorectal Cancer
一项针对转移性BRAF突变型结直肠癌的恩科拉非尼联合西妥昔单抗(加或不加阿培利西布)的Ib期剂量递增研究
期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-16-0795
van Geel, Robin M J M; Tabernero, Josep; Elez, Elena; Bendell, Johanna C; Spreafico, Anna; Schuler, Martin; Yoshino, Takayuki; Delord, Jean-Pierre; Yamada, Yasuhide; Lolkema, Martijn P; Faris, Jason E; Eskens, Ferry A L M; Sharma, Sunil; Yaeger, Rona; Lenz, Heinz-Josef; Wainberg, Zev A; Avsar, Emin; Chatterjee, Arkendu; Jaeger, Savina; Tan, Eugene; Maharry, Kati; Demuth, Tim; Schellens, Jan H M